The Ingestible Smart Pills Market is expected to grow on a persistent note in the future. With AI making its mark everywhere, how could the healthcare vertical be left behind? Abnormalities in the medical scans could be easily spotted by radiologists with the help of machine learning. Likewise, the healthcare vertical is poised to develop on a ravishing note with technological advancements on the anvil in the next decade.
The Ingestible Smart Pills Market will witness a CAGR of 7.7%, reaching US$ 1,000 Million between 2024. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
Advancements in the field of medical technology will continue to be directed towards processes that help manufacturers miniaturize their healthcare products, but without impacting their effectiveness.
Persistence Market Research recently published its report on the global market for ingestible smart pills which projects that high demand for miniaturization of diagnostic disorders is driving the demand for ingestible smart pills. By the end of 2024, the global ingestible smart pills market is projected to grow at 7.7% CAGR and reach US$ 1,475.2 Mn in value.
How About Looking Through The Sample Of Ingestible Smart Pills Market Report? https://www.persistencemarketresearch.co/samples/14371
- Philips Respironics
- Given Imaging Ltd.
- Olympus Corporation
- Proteus Digital Health, Inc.
- CapsoVision, Inc.
- Chongqing Jinshan Science and Component (Group) Co., Ltd.
- IntroMedic Co., Ltd.
- Check-Cap Ltd.
Get A Customized Scope To Match Your Need Ask An Expert – firstname.lastname@example.org
In the report, titled “Ingestible Smart Pills Market: Global Industry Analysis and Forecast, 2016-2024,” the global demand for ingestible smart pills is predicted to surge on the account of following factors:
Increasing Prevalence of Gastrointestinal Disorders: The report estimates that in a region like North America, more than 60 million people are annually diagnosed with gastrointestinal diseases. Early diagnosis of such disorders compels the use of proper endoscopic treatment, which incidentally necessitates the use of ingestible smart pills.
Availability of Accurate Data on Ingestible Smart Pills: Being the next big frontier in novel medical imaging & monitoring technology, ingestible smart pills are being extensively researched and compatible software for deriving data from these pills is being developed, and simultaneously upgraded.
Component Advancements in Endoscopy: New endoscopic components developed by research institutes are treading along the trend of product miniaturization, supporting the inclusion of ingestible smart pills in endoscopic therapies.
Want To Keep A Tab On The Latest Findings In The Ingestible Smart Pills Market? Purchase Our Ingestible Smart Pills Market Report Now! https://www.persistencemarketresearch.com/checkout/14371
According to the report, more than 80% of global ingestible smart pill revenues will be emanating from sales of smart pills, as opposed to workstations. Demand for workstations is expected to witness downtrend towards the latter half of the forecast period.
The report reveals that eight out of ten ingestible smart pills produced in the world will be used for medical imaging applications. In 2016, more than US$ 800 Mn worth of ingestible smart pills were accounted by medical imaging applications.
The present value of global ingestible smart pills market is estimated to be US$ 958.2 Mn. By 2024-end, around 17% of this value will be attributed by revenues arising from sales of ingestible smart pills in health monitoring applications.
About us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com